TP53 MUTATION PROFILE IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FOR A DISEASE SPECIFIC PROFILE FROM A COMPREHENSIVE ANALYSIS OF 268 MUTATIONS

Zenz T, Vollmer D, Trbusek M, Smardova J, Benner A, Soussi T, Helfrich H, Heuberger M, Hoth P, Fuge M, Denzel T, Häbe S, Malcikova J, Kuglik P, Truong S, Patten N, Wu L, Oscier D, Ibbotson R, Gardiner A, Tracy I, Lin K, Pettitt A, Pospisilova S, Mayer J, Hallek M, Döhner H, Stilgenbauer S; European Research Initiative on CLL (ERIC).

Leukemia. 2010 Dec;24(12):2072-9. doi: 10.1038/leu.2010.208. Epub 2010 Sep 23.

FROM PATHOGENESIS TO TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA

Zenz T, Mertens D, Küppers R, Döhner H, Stilgenbauer S.

Nat Rev Cancer. 2010 Jan;10(1):37-50

NEW BIOLOGICAL PROGNOSTIC MARKERS IN CLL

Kostas Stamatopoulos, Paolo Ghia, Richard Rosenquist, Eds.

WKHealth Books| 2010 ISBN: 978-88-7556-551-0

 

This book is free to ERIC members!